Thymic Cancer Experts Discuss the Latest Data, Need for More Research Funding

Season 7 Episode 43  ·  Oct 31, 2022, 07:00 PM

Headliner
Share
Subscribe

Drs Giaccone and He discuss the implications of their thymic cancer research, the importance of combining immunotherapy and anti-angiogenesis agents to treat solid tumors, and the challenges of investigating rare cancers.

Share
Subscribe
Next
FDA Approval Insights: Futibatinib in FGFR2-Positive Cholangiocarcinoma
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air